The FamilyPso tool was created and validated to measure the burden of psoriasis on patients' partners, including domains like ...

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise.

Many doctors do not know how to spot psoriasis in darker skin. This can cause missed or delayed diagnoses. To solve this ...

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

On behalf of our sponsors at Arcutis Biotherapeutics, we're learning more about Plaque Psoriasis, the chronic, inflammatory skin disease that affects many people and a new topical treatment that may ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Quarterly pharmaceutical sales surpassed $15 billion for the first time as strong performance from J&J's cancer medicines ...

Patients with psoriasis have a higher risk for synovitis on imaging than healthy individuals, according to a systematic ...

One of the more serious side effects from immune checkpoint inhibitor (ICI) therapies for cancer is new-onset or worsened ...

A large cohort study of patients with psoriasis using wearable devices finds more exercise is associated with a lower risk ...

A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...

Inverse psoriasis, which causes painful lesions on sensitive skin folds, can be hard to treat. Find out more about this type of psoriasis.